Your institution may have access to this item. Find your institution then sign in to continue.
Title
Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise.
Authors
Stenlöf, K; Cefalu, W T; Kim, K-A; Alba, M; Usiskin, K; Tong, C; Canovatchel, W; Meininger, G
Abstract
Canagliflozin is a sodium glucose co-transporter 2 inhibitor in development for type 2 diabetes mellitus (T2DM). The efficacy and safety of canagliflozin were evaluated in subjects with T2DM inadequately controlled with diet and exercise.